Atrion Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ATRI research report →
Companywww.atrioncorp.com
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally. Its fluid delivery products include valves that fill, hold, and release controlled amounts of fluids or gasses for use in various intubation, intravenous, catheter, and other applications in the anesthesia and oncology fields, as well as promote infection control in hospital and home healthcare environments. The company's cardiovascular products comprise Myocardial Protection System that delivers fluids and medications and mixes critical drugs, as well as controls temperature, pressure, and other variables; cardiac surgery vacuum relief valves; silicone vessel loops for retracting and occluding vessels; and inflation devices for balloon catheter dilation, stent deployment, and fluid dispensing, as well as products for use in heart bypass surgery.
- CEO
- David A. Battat
- IPO
- 1980
- Employees
- 712
- HQ
- Allen, TX, US
Price Chart
Valuation
- Market Cap
- $809.44M
- P/E
- 41.72
- P/S
- 4.78
- P/B
- 3.33
- EV/EBITDA
- 21.40
- Div Yield
- 1.91%
Profitability
- Gross Margin
- 36.84%
- Op Margin
- 13.33%
- Net Margin
- 11.46%
- ROE
- 8.05%
- ROIC
- 7.89%
Growth & Income
- Revenue
- $169.33M · -7.73%
- Net Income
- $19.41M · -44.55%
- EPS
- $11.02 · -43.75%
- Op Income
- $22.58M
- FCF YoY
- 53.24%
Performance & Tape
- 52W High
- $503.24
- 52W Low
- $274.98
- 50D MA
- $455.95
- 200D MA
- $400.15
- Beta
- 0.69
- Avg Volume
- 27.59K
Get TickerSpark's AI analysis on ATRI
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 21, 24 | STUPP JOHN P JR | sell | 879.12 |
| Aug 21, 24 | STUPP JOHN P JR | sell | 135,000 |
| Aug 21, 24 | Spaulding Ronald Nicholas | sell | 2,678 |
| Aug 21, 24 | Spaulding Ronald Nicholas | sell | 312.51 |
| Aug 21, 24 | Athey Preston G | sell | 312.51 |
| Aug 21, 24 | Athey Preston G | sell | 1,368 |
| Aug 21, 24 | Bankes Jeannette | sell | 312.51 |
| Aug 21, 24 | Bankes Jeannette | sell | 186 |
| Aug 21, 24 | BATTAT EMILE A | sell | 150,616 |
| Aug 21, 24 | BATTAT EMILE A | sell | 310.87 |
Our ATRI Coverage
We haven't published any research on ATRI yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ATRI Report →